Associations of Calciprotein Particle Maturation Time with Echocardiographic Measures in the CRIC Study

Ashwin Sunderraj1,2, Xuan Cai3, Andreas Pasch4,5

  • 1Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

PubMed

Insights

T50, a measure of mineral stress, did not show an association with left ventricular abnormalities in chronic kidney disease patients after adjusting for key health factors. This finding suggests T50 may not be a reliable predictor of cardiac changes in this population.

Area of Science:

  • Nephrology
  • Cardiology
  • Biochemistry

Background:

  • Vascular calcification is prevalent in chronic kidney disease (CKD) and linked to poor cardiac outcomes.
  • T50 quantifies mineral stress and is implicated in vascular calcification.

Purpose of the Study:

  • To investigate the association between T50 and left ventricular (LV) echocardiographic abnormalities in CKD patients.
  • To determine if mineral stress (T50) predicts cardiac structural changes in the Chronic Renal Insufficiency Cohort (CRIC).

Main Methods:

  • Cross-sectional analysis using linear and multinomial logistic regression models.
  • Examined associations of T50 with LV mass index, concentric remodeling, and concentric/eccentric hypertrophy.
  • Adjusted for demographics, clinical factors, cardiovascular disease history, and kidney function (eGFR).

Main Results:

  • In unadjusted models, lower T50 was linked to increased LV mass and hypertrophy.
  • After multivariable adjustment, these associations were no longer significant for LV mass index, eccentric hypertrophy, or concentric hypertrophy.
  • No significant association remained between T50 and LV abnormalities after accounting for confounders.

Conclusions:

  • T50 was not significantly associated with left ventricular remodeling or hypertrophy in CKD patients.
  • Multivariable adjustment, including kidney function, attenuated any observed associations.
  • T50 may not be an independent predictor of echocardiographic abnormalities in this cohort.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
876
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
536
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
578
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
538
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
952
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
286